This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Product development is unique in biopharma in the degree of separation between product developers (R&D scientists) and end users (patients…
Article
1 year ago ●
10 mins read
In 2022, Amgen acquired ChemoCentryx for $4B in cash, primarily for avacopan, a first-in-class treatment approved in 2021 for a…
molecule
6 months ago ●
2 mins read
This short article and poster summary takes a deeper look into the 2021 IPOs for biotechnology-based therapeutics being developed by…
Article
1 year ago ●
5 mins read
Emraclidine (CVL-231) is a selective positive allosteric modulator (PAM) of the cholinergic M4 muscarinic receptor and is the only selective…
molecule
6 months ago ●
1 min read
This article is Part 3 of a review series covering all of the initial public offerings for the biotech and…
Article
1 year ago ●
5 mins read
YCT529 (YourChoice) is a potential non-hormonal male contraceptive with impressive preclinical oral efficacy that is expected to enter clinical development…
molecule
6 months ago ●
4 mins read
Load More
